About
Cancer Vaccines
Areas of Focus
Categories
Vaccine
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
68
By Phase
PHASE1: 3PHASE2: 1
By Status
UNKNOWN: 2COMPLETED: 2
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT00532974Lead Sponsor
A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART)
PHASE1Unknown
32 participants
Started: Oct 31, 2006 · Completed: Apr 30, 2008
NCT00104780Lead Sponsor
Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
PHASE2Unknown
Started: Dec 31, 2004
NCT00054912Lead Sponsor
An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer
PHASE1Completed
18 participants
Started: Feb 28, 2003
NCT00054899Lead Sponsor
An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer
PHASE1Completed
18 participants
Started: Jan 31, 2003
Locations (1)
Headquarters
Lyon, France
Map
Loading map...